Status:
COMPLETED
Evaluation of L-PRF as an Antibiotic Slow-release Biological Device in the Treatment of Moderate Periodontitis
Lead Sponsor:
Yasmeen Khaled
Conditions:
Periodontitis
Eligibility:
All Genders
25-50 years
Phase:
PHASE2
PHASE3
Brief Summary
This study aimed to evaluate the efficacy of leukocyte platelet-rich fibrin (L-PRF) as a local sustained released device for antibiotics.
Eligibility Criteria
Inclusion
- Patients suffering from stage II periodontitis with probing depth and exhibiting bleeding on probing.
- Patients showing good oral hygiene.
- No history of periodontal therapy (surgical and non-surgical) for the past 6 months.
Exclusion
- Patients with known systemic and debilitating diseases.
- Patients who had any previous adverse reactions to the products (or similar products) used in this study.
- Patients who have any autoimmune diseases.
- Patients who have any known disease that interfere with periodontal procedure.
- Smokers.
- Pregnancy and lactating women.
- Use of antibiotics during the last 6 months.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2023
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT06153706
Start Date
June 1 2022
End Date
October 1 2023
Last Update
December 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Dentistry, Alexandria University
Alexandria, Egypt